Breast cancer biomarkers.
Substantial progress has been made over the past three decades in our understanding of the epidemiology, clinical course and basic biology of breast cancer. This chapter considers the existing ancillary tests and emerging molecular markers in breast cancer prognosis assessment and the prediction of response of breast cancer to treatment of the disease.
Ross
Jeffrey S
JS
Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208, USA.
Symmans
W Fraser
WF
Pusztai
Lajos
L
Hortobagyi
Gabriel N
GN
D014408:Biomarkers, Tumor / Q000032:analysis; D001943:Breast Neoplasms / Q000175:diagnosis*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D009363:Neoplasm Proteins / Q000032:analysis; D011379:Prognosis; D040901:Proteomics; D016896:Treatment Outcome
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins